Federal Drug Supply Chain Security Act (DSCSA) / Accessing Serialized Transaction Data

What is the U.S. Federal Drug Supply Chain Security Act (DSCSA)?

In 2013, the United States Food and Drug Administration (FDA) enacted the Drug Supply Chain Security Act (DSCSA), a ten-year phased approach with requirements aimed at deterring, detecting and removing potentially dangerous drugs from the supply chain.

ALK is committed to ensuring the integrity and safety of our supply chain. We embrace product identification and have a comprehensive serialization and traceability program that delivers benefits to our patients, customers and the industry.

ALK has met every milestone for the November 27, 2023 deadline and is extending robust supply chain security, traceability and reporting to all customers.

Should you have any questions, please refer to our list of contacts below.

General DSCSA Inquiries or Delivery Issues
Email: DSCSA_Exceptions@alk.net

TI/TS Data Issues
Contact us at DSCSA_Exceptions@alk.net

Transaction Data
Serialized transaction information has been sent electronically to system integrated trading partners via Electronic Product Code Information Systems (EPCIS). All other trading partners that would like to access their serialized transaction data via our web portal will be required to opt-in for this access.  Click here to opt-in.

Once your opt-in request has been processed, you will be able to access your serialized transaction data from that point forward on our web portal: https://sta.ich4ls.cloud.sap/index.html#/staLogin/ALK_DSCSA

Single Transaction Access portal instructions

Should you require additional assistance, please contact ALK Customer Service
(800) 325-7354 or customerservices@alk.net.